Literature DB >> 19035303

SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.

Xiao-Ping Zang1, J Thomas Pento.   

Abstract

BACKGROUND: Keratinocyte growth factor (KGF) produces a rapid increase in the proliferation and motility of estrogen receptor (ER)-positive breast cancer cells which is abolished by estrogen deprivation and/or anti-estrogen treatment. The present study examined the hypothesis that ER-alpha is involved in the KGF proliferation in MCF-7 cancer cells using small interfering RNA (siRNA) to selectively inhibit ER-alpha expression.
MATERIALS AND METHODS: At 48 hours following ER-alpha siRNA transfection, the MCF-7 cells were treated with KGF (50 ng/ml) or vehicle for 24 hours. Cell proliferation was measured using a MTT assay. ER-alpha protein levels were quantified by Western blotting.
RESULTS: ER-alpha siRNA transfection significantly reduced ER-alpha expression and MCF-7 cell proliferation. KGF-mediated enhancement of cell proliferation and motile cell morphology were reduced or absent in the siRNA transfected MCF-7 cells.
CONCLUSION: ER-alpha expression is associated with KGF-induced proliferation of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035303

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Silencing of Survivin Expression Leads to Reduced Proliferation and Cell Cycle Arrest in Cancer Cells.

Authors:  Yuhuan Li; Da Liu; Yulin Zhou; Yujing Li; Jing Xie; Robert J Lee; Yong Cai; Lesheng Teng
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

2.  Validation of the Cancer BioChip System as a 3D siRNA screening tool for breast cancer targets.

Authors:  Joie N Marhefka; Rula A Abbud-Antaki
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

3.  Topical KGF treatment as a therapeutic strategy for vaginal atrophy in a model of ovariectomized mice.

Authors:  Simona Ceccarelli; Sirio D'Amici; Enrica Vescarelli; Paolo Coluccio; Pietro Matricardi; Cira di Gioia; Pierluigi Benedetti Panici; Ferdinando Romano; Luigi Frati; Antonio Angeloni; Cinzia Marchese
Journal:  J Cell Mol Med       Date:  2014-08-01       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.